In the study, elderly individuals with high level inflammation and metabolic syndrome were more likely to develop cognitive impairment than those with high level of inflammation but no metabolic syndrome.2 In contrast, another report from the Health ABC study11 (n=1,323) did not find any significant association between the slope or baseline level of CRP and cognitive decline. The gene discussed is CRP; the disease is metabolic syndrome.